MEDINET Co., Ltd.
MEDINET Co., Ltd. scores highest on Torque (41) and lowest on Earnings (0). Its PosiPenta is 21.48 out of 100, weaker than most similar companies.
On the Penta Grid this week, MEDINET Co., Ltd. is Grid #83 of 91 in the Healthcare sector in Japan, and Grid #1,320 of 1,383 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| MEDINET Co., Ltd. | 21.48 | 23 | 0 | 17 | 41 | 26 |
| Shigematsu Works Co., Ltd. | 57.15 | 95 | 69 | 26 | 41 | 55 |
| SUSMED,Inc. | 33.21 | 28 | 50 | 3 | 57 | 29 |
| CellSource Co., Ltd. | 46.66 | 42 | 60 | 20 | 77 | 35 |
| Cyfuse Biomedical K.K. | 22.86 | 16 | 8 | 45 | 25 | 21 |
| Precision System Science Co., Ltd. | 48.53 | 58 | 52 | 40 | 56 | 37 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.07 |
| P/B ratio | 1.65 |
EEarnings
| Trailing EPS | ₹-188.48 |
| Forward EPS | — |
NNitro
| Price | 12.69 |
| 52-week high | 23.56 |
| 52-week low | 12.08 |
| Fall from 52-week high | 46.2% |
TTorque
| Return on equity (ROE) | -69.34% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 0.40 |
| Market cap | ₹357 Cr |
| Insider holding | 9.31% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is MEDINET Co., Ltd.'s PosiPenta score?
MEDINET Co., Ltd.'s PosiPenta is 21.48 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does MEDINET Co., Ltd. stand on the Penta Grid?
On the Penta Grid this week, MEDINET Co., Ltd. is Grid #83 of 91 in the Healthcare sector in Japan, and Grid #1,320 of 1,383 in Japan.
Which PosiPenta pillar is strongest for MEDINET Co., Ltd.?
Torque (durability), with a score of 41 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for MEDINET Co., Ltd.?
Earnings (growth), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.